The World Health Organization (WHO) directs the development of antibiotics towards priority pathogens. WHO has outlined the required antibacterial properties for three priority infections. These measures help focus research on the most pressing health threats. Requirements include specific properties that antibiotics must meet for effective treatment. The aim is to ensure effectiveness against resistant bacteria. WHO thus supports the development of new drugs for these infections.